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A Ab bs st tr ra ac ct t
Xeroderma pigmentosum (XP) is a rare recessive disorder that is characterized by extreme sensitivity to UV light.
UV light exposure results in the formation of DNA damage such as cyclobutane dimers and (6-4) photoproducts.
Nucleotide excision repair (NER) orchestrates the removal of cyclobutane dimers and (6-4) photoproducts as
well as some forms of bulky chemical DNA adducts. The disease XP is comprised of 7 complementation groups
(XP-A to XP-G), which represent functional deficiencies in seven different genes, all of which are believed to be
involved in NER. The main clinical feature of XP is various forms of skin cancers; however, neurological
degeneration is present in XPA, XPB, XPD and XPG complementation groups. The relationship between NER
and other types of DNA repair processes is now becoming evident but the exact relationships between the
different complementation groups remains to be precisely determined. 
Using gene expression analysis we have identified similarities and differences after UV light exposure between
the complementation groups XP-A, XP-C, XP-D, XP-E, XP-F, XP-G and an unaffected control. The results reveal
that there is a graded change in gene expression patterns between the mildest, most similar to the control
response (XP-E) and the severest form (XP-A) of the disease, with the exception of XP-D. Distinct differences
between the complementation groups with neurological symptoms (XP-A, XP-D and XP-G) and without (XP-C,
XP-E and XP-F) were also identified. Therefore, this analysis has revealed distinct gene expression profiles for
the XP complementation groups and the first step towards understanding the neurological symptoms of XP .
I In nt tr ro od du uc ct ti io on n
The structural integrity of chromosomal DNA is of
paramount importance for the survival of a cell, an
organism and indeed an entire species [1]. The faithful
passage of this nucleotide blueprint requires its stable
transition between successive cellular generations [2].
Both replicating and non-replicating DNA are
vulnerable to various forms of errors and lesions that
constitute or lead to gene mutations [3]. To counteract
the effects of mutagenic and carcinogenic agents all
organisms are equipped with a sophisticated network
of DNA repair systems that are essential for genetic
stability [4]. The identification of several cancer
syndromes in humans where the causative factor is a
genetic mutation in a component of one or more ofH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2006; 4(2) 104
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the DNA repair systems has highlighted the importance
of maintaining DNA integrity.
Exogenous DNA mutagenesis is a consequence of
external agents impacting on the integrity of cellular
DNA. These agents can be divided into three classes:
ultraviolet (UV) irradiation, ionising irradiation and
alkylating agents. DNA repair is an important molecular
defence system in which mutations caused by these
agents in actively transcribed genes are preferentially
repaired. All damaged DNA is repaired before DNA
replication to prevent a mutation being transmitted to
daughter cells [5]. DNA repair can occur by one of
three cellular responses that involve direct reversal,
excision or tolerance of the DNA damage. 
UV irradiation primarily results in DNA damage in
the form of 6,4 photoproducts and cyclobutane
pyrimidine dimers which require excision from the
surrounding DNA. Nucleotide excision repair (NER)
involves an enzyme system that hydrolyses two
phosphodiester bonds on either side of a lesion, creating
an oligonucleotide surrounding the damage. NER has
two distinct subpathways, global genomic repair (GGR)
and transcription-coupled repair (TCR). GGR can
operate at any location in the genome, and its efficiency
varies depending on the type of lesion. In contrast, TCR
specifically removes lesions that block RNA polymerases
on the transcribed strands of active genes [6, 7] and
eliminates different lesions at similar rates [8]. 
Since 1991 extensive research has been conducted
on NER in humans. A wealth of information has become
available since the cloning of the human repair genes,
XPA to XPG and ERCC1 [9]. The discovery of defective
NER in individuals with the rare heritable diseases
xeroderma pigmentosum (XP), trichothiodystrophy (TTD)
and Cockayne’s syndrome (CS) and the subsequent
isolation of UV-sensitive mutants of rodent cell lines led
to the cloning of the human repair genes. Before XP
was identified there was relatively little known about
NER and DNA repair in general. As information
regarding XP is accumulated, more is being discovered
about the NER proteins and their involvement in DNA
repair and other processes. The role of UV-induced
DNA damage in skin cancer and the importance of
adequate repair systems to remove the damage are
clearly illustrated in patients with XP [10, 11].
XP is a recessively inherited genetic disorder, which
occurs at a frequency of 1:250,000 in the United
States, but has a higher frequency in Japan and
Mediterranean areas [12]. XP patients exhibit a 1000
times greater susceptibility to uniformly distributed
melanomas, basal cell carcinomas and squamous cell
carcinomas in sunlight-exposed areas of skin compared
to unaffected individuals [10, 11, 13]. XP cells cannot
efficiently carry out NER, and as a result there is an
accumulation of errors as the damaged DNA tries to
replicate itself [14]. 
XP includes seven genetic subgroups known as
complementation groups (XP-A to XP-G) that represent
different genes in the NER pathway (Table 1). The
functions of most of the XP and CS proteins associated
with NER have been identified and mutations located
in each of the genes have begun to be correlated with
cellular functions and severity of the disease [15].
Currently, individuals are diagnosed with XP based on
clinical criteria and identification of mutations in one
of the NER genes. TTD and CS are different to XP as
they do not have the higher rate of skin cancers and
are characterized by growth and mental retardation.
Mutation detection in these individuals is time-
consuming and costly as many require multiple genes
to be screened before a mutation is identified. In
addition to the high skin cancer incidence in XP ,
progressive neurological degeneration in the form of
primary neuronal degeneration and mental retardation
occurs in a significant number of patients, which is a
result of mutations in specific XP genes. 
Recent advances in biotechnology have seen the
introduction of technologies that allow large numbers
of genes and proteins to be analysed. This technology
is a useful tool when studying complex disorders such
as XP , which are believed to involve changes in
expression of many genes or proteins. One such
example is microarrays that can detect expression levels
of up to 30,000 genes at the same time. A number of
studies have shown that gene expression profiling can
identify sets of genes that allow identification of disease
subtypes. For example, two distinct forms of diffuse large
B-cell lymphoma were identified using gene profiling
of 96 malignant and normal samples [16]. Similarly,
Sorlie and colleagues [17] found that in a subset of
patients, classification of breast cancer tumours by gene
expression profiles could be used as a prognostic
marker with respect to overall and relapse-free survival.
Oestrogen receptor (ER) positive tumours could also be
divided by gene expression profiles into two distinct
subgroups with differing prognosis. The identification
of distinct profiles for each XP complementation group
would expedite the diagnostic process for new cases of
XP and further our understanding of some of the
biological processes associated with NER deficiency.  H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2006; 4(2) 105
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XP is a well characterized DNA repair disorder with
expected outcomes of gene expression for the NER
pathway after UV light irradiation. However, there is an
unknown biological basis for neurological symptoms
appearing in particular complementation groups of XP .
Recent studies in neurological [18] and psychiatric
disorders [19-21] have reported altered expression of
genes with neurological expression and/or function in
peripheral tissue, suggesting that identification of
differential gene expression between complementation
groups with the presence/absence of neurological
symptoms in peripheral tissues such as skin fibroblasts
may determine the genes or biological mechanisms
involved in these previously unexplained clinical
characteristics of XP . 
In this study, 6000 gene cDNA microarrays were
used to identify altered gene expression in control and
XP fibroblast cell lines after UV light exposure. NER
gene expression was altered in all of the XP cell lines
compared to the control cell line, and distinct gene
expression profiles for each XP complementation group
were identified. Finally, genes involved in the
neurological symptoms present in XPA, XPD and XPG
complementation groups were also identified. This may
shed some light on the biological cause of these
previously unstudied symptoms of XP . 
M Ma at te er ri ia al ls s   a an nd d   m me et th ho od ds s
C Co on nt tr ro ol l  a an nd d  X XP P  f fi ib br ro ob bl la as st t  c ce el ll l  l li in ne es s  
The control fibroblast cell line was obtained from
the Molecular Genetics Laboratory, Hunter Area
Pathology Service, John Hunter Hospital, Newcastle,
Australia. The XP fibroblasts were obtained from the
NIGMS Human Genetic Cell Repository, Coriell Institute
for Medical Research. The following XP cell lines had
T Ta ab bl le e   1 1. .   Genes with brain-related function or expression that were significantly altered in association with neurological symptoms in XP  
A Ac cc c. .   N No o. . N Na am me e F Fu un nc ct ti io on n P P   v va al lu ue e
AA464744 KIAA1111 brain cDNA clone 0.00004
R79082 protein tyrosine phosphatase cellular signalling pathways 0.0004
N35888 phosphomannomutase 2 (PMM2) brain specific glycosylation factor 0.0007
R93912 glycogen synthase kinase 3 beta (GSK3 beta) signal cascade of neuronal apoptosis 0.0008
N70841 GABA-B Receptor 1a neurotransmitter receptor 0.0008
T64482 esterase D/formylglutathione hydrolase expressed predominantly in brain 0.0008
AA463251 nucleosome assembly protein (NAP) induces neuronal apoptosis 0.0008
AA495858 hydroxymethylbilane synthase cell cycle and differentiation in glioma cells 0.0023
AA460927 translin dendritic RNA binding comlex 0.0034
H10965 peroxisomal biogenesis factor 12 (PEX12) catalyses metabolism, peroxisome biogenesis disorder  0.0041
(symptoms include neurodevelopmental delay)
N33331 peroxisome proliferator activated receptor (PPAR) anti-inflammatory and decreases free radical formation 0.0062
AA456830 diacylglycerol kinase (DAGK) myelination 0.0064
AA491225 myotubular myopathy 1 (MTM1) expressed in brain, family members involved  0.0064
in neuromuscular disorders
AA504333 endothelial-monocyte activating polypeptide II  brain inflammatory response 0.0069
(EMAPII)
AA644088 cathepsin C upregulated after brain ischaemia 0.0071
H19522 exostoses-like protein 1 (EXTL1) tumour suppressor, highly expressed in brain 0.0076
transducer of erbB2 (Tob) tumour suppressor, highly expressed in brain 0.0076
AA489331 adenosine deaminase metabolism of adenosine 0.0083H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2006; 4(2) 106
known mutations: XPA (GM00544B) 2bp deletion
A468-A469; XPC (GM00030A) 83bp insertion at 462;
and XPD (GM00435) C to T substitution C2047T. XPE
(GM01389A), XPG (GM3021B) and XPF (GM03542C)
cell lines had a clinical history consistent with previously
reported cases for these complementation groups. All
the fibroblast cell lines were incubated with 1 x DMEM
(10% FCS) at 37°C (5% CO2). To identify differential
gene expression in the control and XP fibroblasts, each
cell line was exposed to UV light to induce NER. A cell
survival study, involving 2 J/m
2 UV light exposure over
a time course followed by trypan blue exclusion to
identify the percentage of cell survival, identified 1 minute
of 2 J/m
2 UV light exposure sufficient to induce NER but
not immediate cell death. Half of the control and XP
cells were exposed to 2 J/m
2 UV light for 1 min in PBS
when 100% confluent, and were allowed to recover for
1 hour.
R RN NA A  e ex xt tr ra ac ct ti io on n  
RNA was extracted from approximately 1 x 10
7
fibroblasts using TRIzol reagent as per manufacturer’s
instructions. Analysis and quantification of the RNA
samples were performed by spectrophotometry (Cary
50 Bio UV-Visible spectrophotometer, Varian) using a
ratio of  A260/A280 as described previously [21]. RNA
integrity was assessed by agarose/formaldehyde gels
as described previously [21].
M Mi ic cr ro oa ar rr ra ay y  p pr ro oc ce ed du ur re e
Total RNA (25 μg) was used for indirect labelling of
first-strand cDNA with Cy3 and Cy5 using the CyScribe
cDNA Post-Labelling Kit (Amersham Pharmacia) as per
manufacturer’s instructions. The labelled cDNA was
hybridized on ResGen 6K cDNA microarrays (Clive and
Vera Ramaciotti Centre for Gene Function Analysis) and
washed as per the CyScribe cDNA Post-Labelling Kit
(Amersham Pharmacia) manufacturer’s instructions.
The microarrays were then scanned with an Axon
4000B microarray scanner and the image captured
using GenePix Pro 3.0 software.
M Mi ic cr ro oa ar rr ra ay y  d da at ta a  a an na al ly ys si is s
The images were captured and analysed using
GenePix Pro 3.0 and results tables containing
fluorescence ratios were obtained. The control and XP
fibroblast cell lines were all performed in duplicate with
reverse labelling of the second microarray. All the reverse
labelled microarray results were inverted to ensure all
results were analysed as a ratio of treated/untreated.
Areas or spots on the arrays that were affected by
background were flagged and excluded from further
analyses. GeneSpring 5.0 (Silicon genetics, USA) was
used to normalize per spot and per array (Lowess curve)
and to a 50
th percentile.
The relatedness of each XP complementation group
and the control fibroblast cell line was tested by
performing unsupervised cluster analysis using distance
and correlation of all of the duplicate microarrays. The
number of genes expressed in control and XP fibrobla-
sts after UV light exposure was measured using a level
of detection two-fold greater than the surrounding
background. The number of genes in each cell line with
greater than 1.5 fold alteration after UV light exposure
was also measured. Statistically significant gene lists
were created comparing the control fibroblasts and XP
complementation groups using a non-parametric test
(Wilcoxon-Mann-Whitney test) with a p-value cutoff of
0.05. Using these lists a dendrogram (experiment tree)
was created using standard correlation to show the
relationships between the expression profiles of the
complementation groups. A second dendrogram (gene
tree) was created to show relationships between the
expression levels of genes across all the complemen-
tation groups. Percentage expected NER activity for each
XP complementation group was then used to determine
the accuracy of the clustering pattern. Significantly
altered gene expression based on presence/absence
of neurological symptoms was identified using the non-
parametric test (Wilcoxon-Mann-Whitney test) with a p-
value cutoff of 0.05. Using this list a second
dendrogram was created to show the relationships
between the profiles of the XP complementation groups.
R Re el la at ti iv ve e  r re ea al l- -t ti im me e  P PC CR R
To confirm altered gene expression of STAT1 and
LSD1 identified by microarray analysis cDNA relative
semi-quantification was performed by real-time PCR
as described previously [21]. 
R Re es su ul lt ts s
G Ge en ne e  e ex xp pr re es ss si io on n  p pr ro of fi il li in ng g
The control fibroblasts expressed more genes than
any of the XP fibroblast cell lines after UV light
irradiation (Fig. 1), indicating that altered expression
due to NER deficiency was being detected. Gene
expression alterations greater than 1.5 fold, specific
to each XP complementation group, were also
identified (Fig. 2). Although there was greater
expression in the control fibroblasts after UV light
treatment, the number of genes altered by greater than
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1.5 fold was greater in some XP complementation
groups, in particular XPD. Conversely, the XPA
fibroblasts showed a low number of genes differentially
expressed by greater than 1.5 fold (Fig. 2), which is
reflective of the low number of genes expressed by the
XPA fibroblast cultures after UV light exposure (Fig. 1). 
To ascertain the relatedness of each XP complemen-
tation group and the control, standard correlation and
distance were used to create a dendrogram to show
relationships between gene expression profiles. Similarity
of gene expression profiles is measured by distance on
a dendrogram. Distance is measured by the vertical
height of the branches of the dendrogram; therefore the
closer the relatedness of one profile to another, the shorter
the vertical branch. A second dendrogram (gene tree)
was created using standard correlation and distance to
show relationships between the expression levels of genes
across the groups. Unsupervised clustering analysis was
used to identify the relatedness of the gene expression
profiles for the control fibroblasts and the XP
complementation groups (Fig. 3). The relatedness of the
control fibroblasts and XP complementation groups, with
the exception of XPD, correlated directly with the expected
percentage of NER activity present in each cell line. XPE
has approximately 45% normal NER activity and was the
most similar to the control profile as measured by distance
on the dendrogram (i.e. there is vertical distance between
all the other XP profiles and the branch joining control
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Control and XP fibroblasts cell line cultures were exposed to UV light.
Numbers of differentially expressed genes were determined by
identifying genes with a greater than 1.5 fold change in expression
after UV light exposure. Similar numbers of genes were differentially
expressed in the control and XP complementation groups with the
exception of XPD which had a considerably higher number of genes
down-regulated by greater than 1.5 fold and XPA which had a low
number of differentially expressed genes, reflective of the low number
of genes expressed in the XPA fibroblasts after UV light exposure
up-regulated
down-regulated
XP results series
F Fi ig g. .   3 3. .   C Cl lu us st te er r   a an na al ly ys si is s   o of f   c co on nt tr ro ol l   a an nd d   X XP P   c co om mp pl le em me en nt ta at ti io on n   g gr ro ou up ps s
a af ft te er r   U UV V   l li ig gh ht t   t tr re ea at tm me en nt t. .   A comparison of control and XP complemen-
tation group with gene expression. Control and XP fibroblasts cell line
cultures were exposed to UV light. Each column represents gene
expression for each of the cell lines after UV light exposure. Down-
regulation is represented as green, up-regulation as red and normal
expression as yellow. The dendrogram on top represents the
relationship between and within the 7 cell lines. The dendrogram on
the side represents relatedness of genes based on expression levels.
The relatedness of the control fibroblasts and XP complementation
groups with the exception of XPD correlated directly with the expected
percentage of NER activity present in each cell line
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and XPE). XPF and XPC have approximately 20% normal
NER activity and were the next closest to the control profile
respectively (represented as the next two shortest branches
of the tree). XPG was closely related to XPF by distance
and has approximately 10% normal NER activity. Finally
XPA and XPD were closely correlated and the furthest in
distance from the control profile. XPA has less than 2%
of normal NER activity and XPD has approximately 30%.
The unsupervised clustering showed that XPA, XPD
and XPG profiles had a high correlation, suggesting
that an alternative parameter to percentage of expected
NER deficiency was influencing the profiles. To
investigate the cause of the XPD profile not correlating
with NER activity, and the presence of the XPA, XPD and
XPG cluster, the presence/absence of neurological
symptoms was used to identify significantly altered
genes. 383 genes were significantly altered in the XP
groups with neurological symptoms (XPA, XPD, XPG)
when compared to the XP groups without the symptoms
(XPC, XPE, XPF). 18 highly altered (P<0.01) genes have
previously been reported to have brain-related function
or expression (Table 1).
Cluster analysis of XP complementation groups
exhibiting neurological symptoms using this list also
identified distinct profiles associated with the symptoms
(Fig. 4). The profiles for XPA, XPD and XPG (Fig. 4 red
branches) were closely related as depicted by small
joining branches, and distinctly different to control,
XPC, XPE and XPF (Fig. 4 blue branches).
S Se em mi i- -q qu ua an nt ti it ta at ti iv ve e  r re ea al l- -t ti im me e  P PC CR R
Semi-quantitative real-time PCR using SybrGreen
was used to confirm altered gene expression identified
by microarray analysis. Initially, the expression of two
housekeeping genes, 18s ribosomal RNA and β-Actin,
were measured for each of the UV-treated and untreated
control and XP fibroblasts cell lines. Two genes, signal
transducer and activator of transcription 1 (STAT1) and
lysine specific demethylase 1 (LSD1), having consistently
altered expression across the cell lines from the
microarray analysis, were chosen for confirmation. STAT1
and LSD1 exhibited similar fold change expression in
the microarray and real-time PCR analysis (Table 2) after
UV light treatment. LSD1 expression was not expressed
at a detectable level in the control fibroblasts after UV
light exposure. These results confirm that the microarray
results were reflective of expression levels in the fibroblast
cell lines before and after UV light treatment.
D Di is sc cu us ss si io on n
Exposure to UV light initiates differential expression
of a high numbers of genes in fibroblasts compared to,
for example, cardiac myocytes [22]. The present study
exemplifies the use of fibroblasts to study gene expression
profiles in disorders with reduced NER activity as a high
number of genes were expressed in the control
fibroblasts after UV light exposure and a diminished
number of genes were observed in the NER-deficient XP
fibroblasts. The distinguishing feature of XP compared
to other NER-deficient disorders is DNA repair or DNA
replication deficiencies involving most of the genome
[23]. For this reason, after UV light irradiation, it is to be
expected that whole genome expression in XP fibroblasts
will be considerably lower than in unaffected fibroblasts,
due to the high levels of damaged DNA. This was
confirmed in this study by the decrease in overall
expression in the XP complementation groups compared
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T Ta ab bl le e   2 2. .   Control and XP complementation groups microarray and relative real-time PCR fold change expression levels after UV light irradiation
C Ce el ll l   L Li in ne e L LS SD D1 1 S ST TA AT T1 1
M Mi ic cr ro oa ar rr ra ay y R Re ea al l- -T Ti im me e   P PC CR R M Mi ic cr ro oa ar rr ra ay y R Re ea al l- -T Ti im me e   P PC CR R
F Fo ol ld d   C Ch ha an ng ge e F Fo ol ld d   C Ch ha an ng ge e F Fo ol ld d   C Ch ha an ng ge e F Fo ol ld d   C Ch ha an ng ge e
control -4.6 N/D -1.9 -5.4
XPA -3.1 -2.2 -7.2 -3.1
XPC -5.8 -2.2 -1.8 -5.2
XPD -12.7 -8.5 -11.6 -3.4
XPE -5.0 -4.5 -2.6 -4.6
XPF -2.8 -2.8 -2.2 -9.3
XPG -5.5 -1.0 -1.5 -3.6
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to the control after UV light treatment. The overall
decrease in numbers of genes expressed was not
reflected, however, in the number of genes altered in
each XP complementation group compared to control.
This result may be due to the NER deficiency resulting in
altered expression of other DNA repair mechanisms,
cell-cycle genes and apoptotic pathways. 
Although all the XP complementation groups have
some level of NER deficiency, they have distinct
characteristics such as differing levels of UV light
sensitivity, skin cancer susceptibility and neurological
symptoms. Distinct gene expression profiles were
identified for each complementation group, with
percentage NER activity showing a relationship to
relatedness of profiles. The XPE profile was the most
similar to the control profile, which is to be expected
as XPE has relatively high levels of NER activity and the
least severe symptoms [24]. The remaining XP
complementation groups followed the pattern of the
lower the percentage NER activity the further the profile
from control, with the exception of XPD. XPD showed
a similar profile to XPA, which has a <2% NER activity,
and was equal furthest from control. 
The presence of neurological symptoms in XPA, XPB,
XPD and XPG has rarely been investigated. In this study,
a list of genes significantly different in XPA, XPD and XPG
compared to control, XPC, XPE and XPF was generated
and cluster analysis performed to identify distinct gene
expression profiles related to the presence of neurological
symptoms. Many of the altered genes have neurological
functions and have previously been reported to be
expressed in brain tissue and, although not one of the
aims of this study, further analysis of the data may identify
underlying causes for the symptoms. This current study
suggests that deficiencies in NER probably result in the
accumulation of DNA damage in neurological tissue,
probably as a result of endogenous insult. 
Finally, relative real-time PCR was used to confirm
the altered expression of two genes in the control and
XP cell lines. STAT1 and LSD1 showed similar expression
between the microarrays and real-time PCR, suggesting
that the microarray data is semi-quantitative, and more
importantly is identifying altered regulation of genes in
each sample tested. 
In conclusion, the data herein suggests that cluster
analysis can identify distinct gene expression patterns
between XP complementation groups. Relative real-
time PCR confirmation has also shown that the data
are representative of gene expression in the control
and XP cell lines before and after UV irradiation. The
identification of distinct gene expression profiles for XP
complementation groups will assist in diagnosis of the
disease as well as further our understanding of the
biology of XP . In addition, the understanding of the
biological cause of neurological symptoms in XP will
be furthered with the instigation of gene expression
profiling in XP complementation groups.
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F Fi ig g. .   4 4. .   C Cl lu us st te er r   a an na al ly ys si is s   o of f   n ne eu ur ro ol lo og gi ic ca al l   s sy ym mp pt to om ms s   p pr re es se en nt t   i in n   c co on nt tr ro ol l
a an nd d   X XP P   c co om mp pl le em me en nt ta at ti io on n   g gr ro ou up ps s. .   A comparison of control and XP
complementation group with presence/absence of neurological
symptoms and gene expression. Control and XP fibroblasts cell line
cultures were exposed to UV light. Each column represents expression
in each of the cell lines of 383 genes significantly differentially
expressed in XP complementation groups with and without neurolo-
gical symptoms. Down-regulation is represented as green, up-
regulation as red and normal expression as yellow. The dendrogram
on top represents the relationship between and within the two groups;
blue branches represent absence and red branches represent
presence of neurological symptoms. The dendrogram on the side
represents relatedness of genes based on expression levels. A cluster
of red branches is clearly depicted in the top dendrogram indicating
a distinct gene expression profile for the presence of neurological
symptoms in XP
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